BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21502699)

  • 1. [Upper urinary tract tumors: endourological management and treatment].
    de Fata FR; González J; Angulo J
    Arch Esp Urol; 2011 Apr; 64(3):279-88. PubMed ID: 21502699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic nephroureterectomy: long-term outcomes.
    Eng MK; Shalhav AL
    Curr Opin Urol; 2008 Mar; 18(2):157-62. PubMed ID: 18303536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endourologic management of upper tract transitional cell carcinoma.
    Clark PE; Streem SB
    ScientificWorldJournal; 2004 Jun; 4 Suppl 1():62-75. PubMed ID: 15349530
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of the distal ureter during nephroureterectomy for upper urinary tract transitional cell carcinoma: a review.
    Gkougkousis EG; Mellon JK; Griffiths TR
    Urol Int; 2010; 85(3):249-56. PubMed ID: 20332611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma of the upper urinary tracts: current knowledge and future perspectives.
    Margulis V; Hutchinson R; Krabbe LM
    Minerva Urol Nefrol; 2016 Aug; 68(4):348-9. PubMed ID: 27404376
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma.
    Mills IW; Laniado ME; Patel A
    BJU Int; 2001 Jan; 87(2):150-62. PubMed ID: 11167633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of endoscopy in the management of upper urinary tract tumors].
    Roupret M; Cussenot O; Chartier-Kastler E; Thibault P; Richard F; Conort P; Traxer O
    Prog Urol; 2006 Nov; 16(5):537-41. PubMed ID: 17175946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma.
    Bachir BG; Kassouf W
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):63-75. PubMed ID: 22149433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hand-assisted laparoscopic nephroureterectomy versus open nephroureterectomy for the treatment of transitional-cell carcinoma of the upper urinary tract.
    Stifelman MD; Hyman MJ; Shichman S; Sosa RE
    J Endourol; 2001 May; 15(4):391-5; discussion 397. PubMed ID: 11394451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing oncologic outcomes in upper tract urothelial carcinoma.
    Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):372-80. PubMed ID: 26756501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental ureterectomy for upper tract urothelial carcinoma: two procedures with different indications.
    Xylinas E; Rouprêt M; Shariat SF;
    Urol Oncol; 2013 Nov; 31(8):1841-3. PubMed ID: 24210083
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of upper urinary tract urothelial carcinoma.
    Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma.
    Razdan S; Johannes J; Cox M; Bagley DH
    J Endourol; 2005 Apr; 19(3):366-71. PubMed ID: 15865529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
    Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H
    J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified "pluck" nephroureterectomy for upper urinary tract disorders: combined endourologic and open approach.
    Kural AR; Demirkesen O; Arar O; Onder AU; Yalçin V; Solok V
    J Endourol; 1997 Apr; 11(2):131-4. PubMed ID: 9107587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of endoscopic techniques in the management of upper tract recurrence after cystectomy and urinary diversion.
    Tomaszewski JJ; Smaldone MC; Ost MC
    J Endourol; 2009 Aug; 23(8):1265-72. PubMed ID: 19591622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.
    Grande P; Rouprêt M
    Nat Rev Urol; 2018 Feb; 15(2):73-74. PubMed ID: 29182602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.